Merida Biosciences

About Merida Biosciences

Merida Biosciences is dedicated to becoming a leader in precision immunology by developing highly specific therapies for autoimmune and allergic disorders, aiming to address the root causes of these diseases with unprecedented precision and durability for better patient outcomes.

Products & Services

Precision Therapies for Autoimmune Diseases:A novel platform targeting and eliminating pathogenic drivers of antibody-driven diseases with high precision to achieve durable clinical responses.

Specialties

Precision Immunology Autoimmune Disease Therapies Allergic Disorder Treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 121000000 MR: - FA: $121 million FAN: 121000000	D: 2025-04-08 FD: 2025-04-08	5 investors

Series A Latest

2025-04-08

$121.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Meike Logtenberg

Director, Discovery Research

D

Dario Gutierrez

Founder & Chief Scientific Officer

M

Matthew Leoni

Chief Medical Officer

M

Michael Naill

SVP, Process & Product Development

T

Tara Reagan

Interim Chief People Officer

D

Dodzie Sogah

Chief Operating Officer

View 47 more team members with Pro

Unlock Full Team Directory

Recent News